Calendar GENFIT Euronext Paris
Stocks
FR0004163111
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
||
| 14.15 EUR | 0.00% |
|
| 07-03 | Genfit soars on news of U.S. reimbursement for a product |  |
| 07-03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
Chart calendar GENFIT
Upcoming events on GENFIT
| 2026-09-29 | Earnings release - Q2 2026 | |
| 2026-11-04 | Sales and Revenue Release - Q3 2026 |
Past events on GENFIT
| 2026-06-15 | Présentation aux Actionnaires / Analystes | 04:00 |
| 2026-06-14 | Extraordinary General Meeting | |
| 2026-06-14 | Annual General Meeting | |
| 2026-05-20 | Sales and Revenue Release - Q1 2026 | |
| 2026-04-02 | Earnings release - Annual 2025 | |
| 2026-02-25 | Sales and Revenue Release - Annual 2025 | |
| 2025-11-19 | Sales and Revenue Release - Q3 2025 | |
| 2025-09-21 | Earnings release - Q2 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 38,2 61,6 -38.07% | 70,9 77,4 -8.31% | 71,1 66,8 6.43% | 100 | 124 | 147 |
|
EBITDA Million EUR | Released Forecast Spread | -24,9 -38,2 34.76% | 5,01 29,4 -82.98% | -51,8 -41,3 -25.29% | 28,1 | 60,7 | 72,1 |
|
EBIT Million EUR | Released Forecast Spread | -26,6 -25,4 -4.81% | 3,28 16,8 -80.47% | -4,50 -5,35 15.87% | 34,2 | 67,0 | 84,9 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -28,5 5,23 -645.39% | 1,85 2,70 -31.59% | -86,5 -5,35 -1515.44% | 42,7 | 126 | 122 |
|
Net income Million EUR | Released Forecast Spread | -28,9 -21,9 -32.17% | 1,51 20,1 -92.51% | -86,0 -8,30 -935.48% | 22,9 | 6,80 | 33,3 |
|
EPS EUR | Released Forecast Spread | -0,58 -0,56 -3.66% | 0,03 0,26 -88.24% | -1,72 -0,10 -1656.36% | 0,39 | 0,15 | 1,10 |
| Announcement Date | 04/04/24 | 24/04/25 | 02/04/26 | - |
Quarterly results
| Fiscal Period | December | 2024 S1 | 2024 Q4 | 2024 S2 | 2025 Q1 | 2025 S1 | 2025 S2 | 2026 Q1 | 2026 S1 | 2026 S2 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 61,2 48,3 26.79% | 11,2 7,30 53.96% | 9,74 23,1 -57.77% | 2,80 133 -97.89% | 35,7 98,6 -63.81% | 35,4 42,1 -15.81% | 9,60 9,50 1.05% | 33,4 | 40,8 |
|
EBIT Million EUR | Released Forecast Spread | 31,2 21,1 48.11% | -27,9 -26,8 -4.26% | 0,08 57,9 -99.87% | -4,50 4,40 -202.29% | |||||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 30,3 22,8 32.93% | -28,5 -27,6 -3.27% | -10,1 57,8 -117.49% | -76,4 3,30 -2415.06% | |||||
|
Net income Million EUR | Released Forecast Spread | 30,3 17,2 76.02% | -28,8 -11,5 -150.47% | -9,96 51,4 -119.37% | -76,0 0,85 -9042.59% | -0,80 | 5,30 | |||
|
EPS EUR | Released Forecast Spread | 0,53 0,49 8.16% | -0,50 -0,55 9.09% | -0,20 2,18 -109.17% | ||||||
| Announcement Date | 19/09/24 | 24/04/25 | 24/04/25 | 22/05/25 | 22/09/25 | 02/04/26 | 21/05/26 | - | - |
| Today |  | Earnings presentation | 16:30 |
| Today | | Earnings release - Q2 2026 | |
| 2026-07-31 | | Annual General Meeting | 06:00 |
| 2026-07-31 | | Extraordinary General Meeting | 02:30 |
| 2026-08-03 | | Earnings presentation | 16:30 |
| 2026-08-03 | | Earnings release - Q2 2026 | |
| 2026-08-04 | | Earnings presentation | 16:30 |
| 2026-08-04 | | Earnings release - Q2 2026 | |
| 2026-08-04 | | Earnings presentation | 16:30 |
| 2026-08-04 | | Earnings release - Q2 2026 |
Past sector events for GENFIT
| Today | | Earnings presentation | 08:00 |
| Today | | Earnings release - Q2 2026 | |
| Today | | Earnings presentation | 04:00 |
| 2026-07-29 | | Earnings release - Q2 2026 | |
| 2026-07-29 | | Earnings release - Q2 2026 | |
| 2026-07-29 | | Earnings presentation | 08:30 |
| 2026-07-29 | | Earnings presentation | 08:00 |
| 2026-07-29 | | Earnings release - Q2 2026 | |
| Today | | Earnings presentation | 23:30 |
| 2026-07-29 | | Annual General Meeting | 06:00 |
- Stock Market
- Stocks
- GNFT Stock
- Stock
- Calendar GENFIT
Select your edition
All financial news and data tailored to specific country editions
